Requip and Droxidopa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Requip (ropinirole hydrochloride) and Droxidopa (droxidopa). Common drug interactions include delirium among females and sudden onset of sleep among males.
The phase IV clinical study analyzes what interactions people have when they take Requip and Droxidopa. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.
What is Droxidopa?
Droxidopa has active ingredients of droxidopa. eHealthMe is studying from 1,093 Droxidopa users. Check the latest studies of Droxidopa.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
22 people who take Requip and Droxidopa together, and have interactions are studied.

What are the common drug interactions of Requip and Droxidopa, by gender? *:
female:
- Delirium (wild excitement)
- Delusion (a false belief or opinion)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Decreased appetite
- Depressed level of consciousness
- Hallucination (an experience involving the perception of something not present)
- Negativism (negative thoughts)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Sudden onset of sleep
- Abdominal discomfort
male:
- Sudden onset of sleep
- Hallucination (an experience involving the perception of something not present)
- Dehydration (dryness resulting from the removal of water)
- Allodynia (a condition in which pain is caused by a stimulus that does not normally elicit pain)
- Cellulitis (infection under the skin)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Peripheral swelling
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Death
- Back disorder
What are the common drug interactions of Requip and Droxidopa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Decreased appetite
30-39:
n/a
40-49:
- Aggression
- Communication disorder (speech and language disorder)
- Dehydration (dryness resulting from the removal of water)
- Delusion (a false belief or opinion)
- Decreased appetite
50-59:
- Cold sweat
- Pallor
- Respiratory depression (respiration has a rate below 12 breaths)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Urticaria (rash of round, red welts on the skin that itch intensely)
60+:
- Hallucination (an experience involving the perception of something not present)
- Pyrexia (fever)
- Death
- Decreased appetite
- Abdominal discomfort
- Asthenia (weakness)
- Back disorder
- Blood glucose increased
- Confusional state
- Contusion (a type of hematoma of tissue in which capillaries)
What are the existing conditions these people have? *
- Parkinson's Disease: 17 people, 77.27%
- Type 2 Diabetes: 2 people, 9.09%
- Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 2 people, 9.09%
- Insomnia (sleeplessness): 2 people, 9.09%
- Hypotension (abnormally low blood pressure): 2 people, 9.09%
- Hallucinations (sensations that appear real but are created by your mind): 2 people, 9.09%
- Dementia With Lewy Bodies (progressive degenerative disease or syndrome of the brain): 2 people, 9.09%
- Delusion (a false belief or opinion): 2 people, 9.09%
- Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Requip and Droxidopa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Requip and Droxidopa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Droxidopa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Droxidopa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ropinirole hydrochloride and droxidopa (the active ingredients of Requip and Droxidopa, respectively), and Requip and Droxidopa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Trazodone Hydrochloride cause Abnormal Loss Of Weight? - 2 seconds ago
- Could Venlafaxine Hydrochloride cause Speech Impairment (Adult)? - 52 seconds ago
- Could Nisoldipine cause Nausea And Vomiting? - a minute ago
- Could Opsumit cause Diarrhea? - a minute ago
- Could Opsumit cause Stools - Watery? - a minute ago
- Could Finacea cause Urticaria? - a minute ago
- Small Intestinal Perforation and drugs of ingredients of warfarin sodium - a minute ago
- Could Acetylcysteine cause Neutrophil Count Increased? - a minute ago
- Could Entresto cause Scratch? - a minute ago
- Adderall 7.5 vs. Amphetamine Sulfate, side effect and effectiveness comparison - a minute ago